C-J Advisory’s Zimmer Biomet ZBH Stock Holding History

C-J Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-90	Closed	-$9K	–	171
2018 Q1	$9K	Hold	90	–	–	0.01%	117
2017 Q4	$10K	Hold	90	–	–	0.01%	114
2017 Q3	$10K	Hold	90	–	–	0.01%	110
2017 Q2	$11K	Sell	90 -93	-51%	-$11K	0.01%	103
2017 Q1	$22K	Hold	183	–	–	0.02%	71
2016 Q4	$18K	Hold	183	–	–	0.02%	85
2016 Q3	$23K	Buy	+183	New	+$22.6K	0.02%	65

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

C-J Advisory's ZBH Position: Q2 2018 in Review

C-J Advisory sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 90 shares — an estimated $9K sold.

C-J Advisory first reported a position in ZBH in Q3 2016 and held it in 7 quarters. The position peaked at $23K in Q3 2016. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

C-J Advisory reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
C-J Advisory sold 90 Zimmer Biomet shares in Q2 2018, an estimated $9K.
C-J Advisory first reported a position in Zimmer Biomet in Q3 2016 and held it in 7 quarters.
C-J Advisory's Zimmer Biomet position peaked at $23K in Q3 2016.
869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on C-J Advisory's 13F filing for Q2 2018, filed 3 May 2019.